Nazara's $95m impairment masks a 66% EBITDA surge and global AI acquisition pivot
Summary
Nazara aligned its FY26 strategy around international M&A after India's Gaming Act triggered a $95m impairment on its real-money gaming stake
FY26 revenue hit $190m, up 13% YoY, while EBITDA surged 66% to $26.5m - an all-time high
The company raised $50m+ earmarked for AI-enabled gaming acquisitions targeting global markets
"Operating leverage is real, and it is compounding. The years ahead are about scaling this platform globally."
01
India's Gaming Act wiped $95m from Nazara's books in a single stroke
India banned all real-money games - skill-based and chance-based - citing addictive design, fraud, and financial ruin
Moonshine Technologies (PokerBaazi operator) ceased its entire business, triggering a ₹9.1bn impairment for Nazara
Profits fell despite 13% revenue growth - regulatory exposure neutralized top-line momentum
For investors with India-facing real-money portfolios, this is now the clearest precedent for binary regulatory risk
02
Non-real-money core hit record EBITDA despite a weak Q4
FY26 EBITDA reached $26.5m, up 66% YoY, with Q4 margins at 19.5% - both all-time highs
Gaming led revenue at $111.3m, ad tech contributed $47.2m, esports added $31.9m
Q4 revenue fell 24% YoY to $41.3m, yet full-year EBITDA still surged
The margin expansion proves Nazara's non-gambling businesses carry independent operating leverage
03
Nazara's regulatory hedge: acquire internationally, build AI-enabled businesses
Agreed to acquire 50% controlling stake in Bluetile Games and its rewarded engagement arm BestPlay Systems in Q4
Raised $50m+ specifically for further international acquisitions and AI-enabled gaming businesses
Bluetile/BestPlay targets engagement-driven and ad-monetized models less exposed to gambling regulation
"FY26 was a pivotal year for Nazara. We delivered our highest-ever EBITDA at ₹2.55bn ($26.5m), with EBITDA growing 66% year-on-year."
Events
Companies
Games
Locations
India
COMPILED BY GAMES ATLAS EDITORIAL
RELATED ARTICLES
EXPLORE MORE
Comments (0)
No comments yet. Be the first to share your thoughts!